In Japan, the Ministry of Health has approved a revolutionary cure for cancer, which is struggling onkokletki with the immune system of the patient.
We are talking about the drug Kymriah, writes Oxford Biomedica.
To manufacture drug filed a branch of a major Swiss pharmaceutical manufacturer Novartis. These drugs will be first drug that uses therapy using CAR-T cells.
The treatment itself begins with the selected cells of the immune system of the patient.
These T-cells are genetically “reprogrammed”. Then these cells back into the patient’s body and destroy their own forces cancer cells.
The drug is prescribed for the treatment of leukemia and other cancers of the blood, which is not yet therapy.
More news regarding the treatment, medicine, nutrition, healthy lifestyle and much more – see Health.